Finding · criterion S3
How can a named compounding pharmacy be verified?
Start with the dispensing pharmacy's exact name and address, then compare them with the relevant state pharmacy board record. A seller's logo or partner list is insufficient.
Identify the dispensing facility
A telehealth brand, medical group, payment company, and dispensing pharmacy can all have different names. The relevant pharmacy is the facility expected to fill the prescription. A statement such as licensed US pharmacy identifies a category without identifying that facility.
A useful disclosure supplies a legal or trading name and a location. Multiple facilities may share a parent company. A familiar parent name cannot establish which address dispenses a particular order. The name on a website should remain distinguishable from the name eventually printed on the prescription label.
Use the board record as the reference
FDA's BeSafeRx directory links to state pharmacy board license databases. The board record is the appropriate starting point for checking the name, address, and current license status. Search results and seller badges should be compared with that record rather than treated as a substitute.
The scope of a record matters. A listing for a similarly named company at another address is an unresolved match. Shipping into another state can introduce additional licensing questions. A public search that does not resolve the facility should be described as unresolved, rather than converted into a claim that the pharmacy is unlicensed.
Check the label and preserve the distinction
FDA has reported fraudulent compounded GLP-1 labels naming pharmacies that did not make the products. A real pharmacy name can therefore appear in a false claim. Where a label or order raises doubt, independent contact with the named pharmacy provides a separate route to clarification.
The ledger's pharmacy criterion asks whether the seller identifies a filling facility. It is a disclosure check, not a continuing license-monitoring service. A named pharmacy improves traceability, but the particular shipment, product, and prescriber remain separate questions. The source date indicates when the website statement was read, not a guarantee that the same facility fills every subsequent order.
Related standard: S3. Pharmacy identification. Evidence for individual companies appears in the seller ledger.
Related reading
Sources
Related findings
Compounded GLP-1 labels: concentration, volume and unitsSyringe units, liquid volume and the amount of medication describe different things. A familiar syringe marking cannot establish a dose when the concentration or prescription has changed. Ask the dispensing pharmacist to reconcile the prescription, label and supplied syringe.
What does 503A or 503B actually establish about a seller?503A and 503B describe different federal compounding frameworks. Neither label identifies the filling facility by itself, and neither makes a compounded drug FDA-approved.
How many peptide sellers name the pharmacy that fills the order?A minority. Most sellers substitute a legal category, such as a licensed 503A pharmacy, for a facility a reader could look up in a state board register.
Which pharmacies fill the orders, and how many sellers name the same one?Fewer facilities than storefronts. Several sellers that look like separate businesses name the same filling pharmacy, and one facility appears in the ledger under several different spellings, each written by a different seller.